News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
416,653 Results
Type
Article (27465)
Company Profile (157)
Press Release (389031)
Section
Business (127495)
Career Advice (1250)
Deals (22894)
Drug Delivery (98)
Drug Development (60816)
Employer Resources (122)
FDA (9696)
Job Trends (9588)
News (225033)
Policy (20929)
Tag
Academia (1514)
Alliances (33534)
Alzheimer's disease (809)
Approvals (9673)
Artificial intelligence (108)
Bankruptcy (198)
Best Places to Work (7150)
Biosimilars (74)
Breast cancer (116)
Cancer (884)
Cardiovascular disease (86)
Career advice (1024)
Cell therapy (148)
Clinical research (49909)
Collaboration (304)
Compensation (94)
COVID-19 (1709)
C-suite (73)
Data (973)
Diabetes (142)
Diagnostics (2825)
Drug pricing (99)
Earnings (45337)
Employer resources (111)
Events (59409)
Executive appointments (287)
FDA (10111)
Funding (256)
Gene therapy (123)
GLP-1 (575)
Government (2449)
Healthcare (9518)
Infectious disease (1779)
Inflammatory bowel disease (93)
Interviews (189)
IPO (9199)
Job creations (2722)
Job search strategy (922)
Layoffs (288)
Legal (4908)
Lung cancer (133)
Lymphoma (76)
Manufacturing (162)
Medical device (4561)
Medtech (4565)
Mergers & acquisitions (13808)
Metabolic disorders (427)
Neuroscience (1053)
NextGen Class of 2024 (3703)
Non-profit (2162)
Northern California (913)
Obesity (259)
Opinion (188)
Patents (90)
People (40206)
Pharmaceutical (82)
Phase I (14932)
Phase II (21424)
Phase III (17350)
Pipeline (366)
Policy (77)
Postmarket research (1946)
Preclinical (5481)
Radiopharmaceuticals (176)
Rare diseases (193)
Real estate (3818)
Regulatory (14559)
Research institute (1448)
Resumes & cover letters (185)
Southern California (854)
Startups (2523)
United States (8645)
Vaccines (387)
Weight loss (212)
Date
Today (2)
Last 7 days (226)
Last 30 days (1410)
Last 365 days (21615)
2024 (21563)
2023 (24175)
2022 (32033)
2021 (33974)
2020 (32294)
2019 (27762)
2018 (21437)
2017 (21676)
2016 (20775)
2015 (24354)
2014 (18604)
2013 (15348)
2012 (16583)
2011 (17175)
2010 (15516)
Location
Africa (526)
Asia (29661)
Australia (4321)
California (2098)
Canada (960)
China (220)
Colorado (96)
Connecticut (93)
Europe (64393)
Florida (309)
Georgia (77)
Illinois (244)
Indiana (156)
Maryland (361)
Massachusetts (1699)
Minnesota (132)
New Jersey (779)
New York (651)
North Carolina (442)
Northern California (913)
Ohio (79)
Pennsylvania (512)
South America (782)
Southern California (854)
Texas (301)
Washington State (244)
416,653 Results for "merz pharma group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Merz Enters Asset Purchase Agreement With a US-Based Biotech Company
Merz Therapeutics, a business of Frankfurt-based Merz Group, has entered into an Asset Purchase Agreement to acquire two commercial medicines from NASDAQ-listed Acorda Therapeutics.
April 2, 2024
·
3 min read
Deals
Acorda Joins Growing Group of Biotechs Filing for Bankruptcy, Divests Assets to Merz
Acorda Therapeutics becomes the latest biotechnology company in 2024 to go bankrupt and shutter its business, following years of financial difficulty. Merz Therapeutics will acquire two commercial medicines from Acorda for $185 million.
April 3, 2024
·
2 min read
·
Tristan Manalac
Press Releases
LSL PHARMA GROUP SECURES A NEW $5.0 MILLION TERM LOAN
December 23, 2024
·
4 min read
LSL Pharma Group Completes the Acquisition of Virage Santé
LSL PHARMA GROUP INC., a Canadian integrated pharmaceutical company, is pleased to announce the completion of the acquisition of Virage Santé, a company specializing in the manufacturing and marketing of natural health products, based in Lévis, Quebec.
June 18, 2024
·
3 min read
Business
LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders
LSL PHARMA GROUP INC., a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held in Montréal, Québec.
June 28, 2024
·
3 min read
Business
Envision Pharma Group Announces the Appointment of Alistair Macdonald to Board of Directors
Envision Pharma Group announced the appointment of Alistair Macdonald to the Envision Board of Directors.
May 8, 2024
·
2 min read
Business
LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024
LSL PHARMA GROUP INC. (TSXV: LSL) (the “Corporation” or “LSL Pharma "), a Canadian integrated pharmaceutical company, today reported its financial results for the first quarter of fiscal year 2024 ended on March 31, 2024.
May 30, 2024
·
7 min read
Press Releases
BGM Group Welcomes Guilin Pharma for On-site Audit and Partnership Development
November 22, 2024
·
3 min read
LSL Pharma Group Secures $1.5 Million as the First Closing of Its Non-Brokered Private Placement
LSL PHARMA GROUP INC. announced that it has met the closing conditions of a non-brokered private placement for $1,5 million representing the first closing of the private placement financing announced on June 5, 2024.
June 27, 2024
·
5 min read
Business
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors
LSL PHARMA GROUP INC. announced the appointment of Diane Beaudry and Mario Paradis to its Board of Directors.
April 23, 2024
·
4 min read
1 of 41,666
Next
